Angela Onwuzoo Fidson Healthcare Plc has signed a Strategic Cooperation Memorandum with three Chinese firms; Jiangsu Aidea Pharma, Nanjing PharmaBlock, and the China-Africa Development Fund in Beijing, China, to expand access to HIV drugs in Africa. Through this collaboration, the four firms have agreed to actively leverage their respective strengths to establish a new joint venture pharmaceutical plant project in Nigeria. The signing ceremony took place during a visit by a team from Nigeria led by Dr.
Fidelis Ayebae, the founder and Managing Director of Fidson Healthcare Plc. Other members of the delegate from Nigeria were Dr. Babatunde Ipaye and Mr.
Oshoke Ayebae. Ayebae, in a statement, said the partnership would help Nigerians and other Africans living with HIV to have access to treatment. “Through this collaboration, the four parties have agreed to actively leverage their respective strengths to establish a new joint venture pharmaceutical plant project in Nigeria.
“This new project is poised to promote Africa’s self-reliance in healthcare delivery especially to tackle HIV. “All parties agreed to share information and resources, jointly explore investment opportunities in the pharmaceutical markets of West African countries, and implement investment cooperation at the project level”, he said. The Fidson boss noted that the signing ceremony followed a series of engagements which included a visit by the Chairman of Jiangsu Aidea Pharma- Dr.
Heliang Fu to Nigeria .